JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 41 No. 6 1102-1107
© 2000 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imahashi, K.
Right arrow Articles by Nishimura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imahashi, K.
Right arrow Articles by Nishimura, T.

Kinetics of a Putative Hypoxic Tracer, 99mTc-HL91, in Normoxic, Hypoxic, Ischemic, and Stunned Myocardium

Kenichi Imahashi, Kenichi Morishita, Hideo Kusuoka, Yoshihiro Yamamichi, Shinji Hasegawa, Katsuji Hashimoto, Yoshifumi Shirakami, Makoto Kato-Azuma and Tsunehiko Nishimura

Division of Tracer Kinetics, Osaka University Graduate School of Medicine, Suita, Osaka
Research Center, Nihon Medi-Physics Co., Ltd., Sodegaura, Chiba
Institute for Clinical Research, Osaka National Hospital, Chuo-ku, Osaka, Japan

Correspondence: For correspondence or reprints contact: Tsunehiko Nishimura, MD, PhD, Division of Tracer Kinetics, Osaka University Graduate School of Medicine, D9, 2-2 Yamadaoka, Suita, Osaka, 565-0871 Japan.

ABSTRACT

99mTc-4,9-diaza-3,3,10,10-tetramethyldodecan-2,11-dione dioxime (HL91) was developed as a putative hypoxic reagent. This study focused on the myocardial kinetics of 99mTc-HL91 in various oxygen levels and perfusion states. Methods: The time-activity curve of 99mTc-HL91 was measured in isolated perfused rat heart after the bolus infusion. Results: 99mTc-HL91 was cleared quickly from normoxic hearts, and retention at 30 min after injection was 0.18 ± 0.02 percentage injected dose per gram of wet weight (mean ± SE; n = 6). When the concentration of oxygen bubbling through the perfusate was reduced from 100% to 50%, 20%, 5%, and 0%, retention of <99mTc-HL91 increased to 0.47 ± 0.03 (n = 5), 0.48 ± 0.03 (n = 5), 0.71 ± 0.01 (n = 5), and 0.70 ± 0.02 (n = 5), respectively (P < 0.05). Compartment analysis revealed that the trapping mechanism, which was dependent on tissue oxygen concentration, determined the retention rate. Although not retained in stunned myocardium (0.17 ± 0.02, n = 5; P = not significant), 99mTc-HL91 was significantly retained when injected before ischemia (1.06 ± 0.06, n = 5; P < 0.05). Conclusion: These results indicate that retention of 99mTc-HL91 correlates well with oxygen level in the perfusate, suggesting that the agent may be a useful marker of the severity of myocardial hypoxia.

Key Words: radioisotopes • hypoxia • ischemia • myocardial stunning




This article has been cited by other articles:


Home page
JNMHome page
S.-M. Eschmann, F. Paulsen, M. Reimold, H. Dittmann, S. Welz, G. Reischl, H.-J. Machulla, and R. Bares
Prognostic Impact of Hypoxia Imaging with 18F-Misonidazole PET in Non-Small Cell Lung Cancer and Head and Neck Cancer Before Radiotherapy
J. Nucl. Med., February 1, 2005; 46(2): 253 - 260.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2000 by the Society of Nuclear Medicine.